Ovintiv closed at $62.70 on Nov 4, down 5.61%, 13.7% below its 52-week closing high. Volume of 5.7M shares was 1.71× its 20-day average (above normal).
Split-adjusted performance: +2.0% over one month, +4.7% over six months, +67.0% over one year.
In the quarter ended Sep 30, 2026, revenue was $2.60B, up 25.9% from a year earlier, with a net margin of 21.1%.
Short interest was 12.7M shares at the Oct 15 settlement, up 20.1% from the prior report (4.6% of float, 4.1 days to cover).